• About us
• Contact

Advertisement

Document › Details

PerkinElmer, Inc.. (7/24/17). "Press Release: PerkinElmer Board Declares Quarterly Dividend". Waltham, MA.

	Organisation	PerkinElmer Inc. (NYSE: PKI)
	Group	PerkinElmer (Group)
	Product	analytical instrument
	Product 2	diagnostics (medical/biological)
	Person	Thomas, Tommy J. (PerkinElmer 201501 Investor Relations Manager)
	Person 2	Willinsky, Brian (PerkinElmer 201403)

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on July 24, 2017. This dividend is payable on November 10, 2017 to all shareholders of record at the close of business on October 20, 2017.


About PerkinElmer

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of 9,000 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. The Company reported revenue of approximately $2.1 billion in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com


PerkinElmer, Inc.

Investor Relations:
Tommy J. Thomas, 781-663-5889
tommy.thomas@perkinelmer.com

or

Media:
Brian Willinsky, 781-663-5728
brian.willinsky@perkinelmer.com

Record changed: 2023-06-05

Advertisement

More documents for PerkinElmer (Group)

• [1] Moderna, Inc.. (8/17/22). "Press Release: James Mock Joins Moderna as Chief Financial Officer". Cambridge, MA....
• [2] PerkinElmer, Inc.. (7/26/21). "Press Release: PerkinElmer to Acquire Antibody and Reagent Leader BioLegend". Waltham, MA....
• [3] PerkinElmer, Inc.. (6/22/21). "Press Release: PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader Sirion Biotech". Waltham, MA....
• [4] PerkinElmer, Inc.. (5/17/21). "Press Release: PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC". Waltham, MA....
• [5] PerkinElmer, Inc.. (5/12/21). "Press Release: PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience". Waltham, MA....
• [6] PerkinElmer, Inc.. (1/7/21). "Press Release: PerkinElmer to Acquire Oxford Immunotec Global plc". Waltham, MA & London....
• [7] PerkinElmer, Inc.. (12/16/20). "Press Release: PerkinElmer to Present at J.P. Morgan Healthcare Conference". Waltham, MA....
• [8] PerkinElmer, Inc.. (11/2/20). "Press Release: PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million)". Waltham, MA....
• [9] Lynch, Sara N. [Reuters]. (5/18/20). "News: Exclusive – U.S. Probes PerkinElmer's Role in Massive Medicare Fraud –Sources". Washington....
• [10] PerkinElmer, Inc.. (8/21/19). "Press Release: PerkinElmer Announces Leadership Succession Plan". Waltham, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.